# Arcutis Biotherapeutics, Inc. (ARQT): MoatMap facts

As of 24 Oct 2026. Research data, not investment advice.

As of 24 Oct 2026, MoatMap's StockRank for Arcutis Biotherapeutics, Inc. (ARQT) is 53/100, ranked against 24,000+ stocks in 35 markets (Quality 67, Value 10, Momentum 69, each scored against its sector).

- StockRank: 53/100, a percentile across 24,000+ stocks in 35 markets (100 is best).
- Quality 67, Value 10, Momentum 69: each a 0-100 percentile within Healthcare.
- Position: #12,709 overall, #1,169 in Healthcare.
- Listing: United States, NMS; Healthcare / Biotechnology.
- Last close: 31.81 USD on 26 Oct 2026.
- Insider filings, last 180 days: directors sold USD 2.8M.

Source: https://moatmap.ai/stock/ARQT
How the scores work: https://moatmap.ai/methodology
Does StockRank work? The public record: https://moatmap.ai/decile-tracker